May repairs full of mistakes develop into cancer?
A group of researchers at Osaka University found that if DNA damage response (DDR) does not work when DNA is damaged by radiation, proteins which should be removed remain instead, and a loss of genetic information can be incited, which, when repaired incorrectly, will lead to the tumor formation.

These are DNA double-strand breaks, introduced by ionizing radiation or other mechanisms, are repaired rapidly and precisely in normal cells (right pathway). In contrast, compromised Tel1 activation with inefficient end joining activity in the mutant promotes accumulation of Ku protein at single-stranded DNA ends at the damaged site, and then, results in imprecise repair of genomic DNA (left pathway).
Osaka University
It is thought that one of the reasons why cells become cancerous is that the source of genetic information is physically destroyed. Our body has a system to repair DNA damage (DNA repair mechanism), so why a normal cell turns into a cancer cell and why radiation exposure causes cancer have not been clarified.
Radiation damages genomic DNA, the essential blueprint for life; therefore, living organisms have several mechanisms for maintaining the stability of their own genomes. Although they have big evolutionary differences, both humans and budding yeast contain proteins that perform the same function. Miki Shinohara, associate professor and her group at the Institute for Protein Research, Osaka University examined the DNA repair function of yeast Xrs2, an orthlog of human Nbs1, and yeast Tel1, an orthlog of human ATM.
Mutations in the Nbs1 gene are responsible for a human hereditary disorder which develops a high risk of cancer. This group found that DNA damage was repaired when human hereditary disorder type mutations (xrs2 mutations) were introduced in yeast XRS2 genes, but it was repaired with more errors than a DNA sequence with no mutations. This group determined that the cause was that the function of the Tel1 protein, which is important for DNA damage response, was not fully implemented in xrs2 mutations.
In the process of DNA repair through homologous recombination, it is necessary to make double-stranded DNA near DNA lesions into single-stranded DNA. This group clarified that Ku remained on DNA damage in tel1 mutants and xrs2 mutants. Ku is not required, so it should be removed when DNA damage is repaired.
Ku is a protein to join DNA ends broken by non-homologous end joining (NHEJ). It is thought that Ku, a repair tool, joins DNA ends where Ku normally should not work, and as a result, repair is completed with incorrect DNA information.
Tumor formation occurs when genomic DNA is broken or errors have become continuous. In human cells as well, if Nbs1 and ATM function in the same way to ensure repair of DNA damage, tumor formation may be prevented.
This group's achievement shows the possibility to clarify the mechanism of human tumor formation, especially the molecular mechanism responsible for in the initial stage of cell cancerization due to DNA damaged by radiation in the initial stage, by using the model of budding yeast, a primitive eukaryote. Furthermore, it may be possible to clarify the molecular mechanism of cancerization by radiation exposure by verifying it using human cells.
Original publication
Most read news
Original publication
Daichi Iwasaki, Kayoko Hayashihara, Hiroki Shima, Mika Higashide, Masahiro Terasawa, Susan M. Gasser, Miki Shinohara; "The MRX Complex Ensures NHEJ Fidelity through Multiple Pathways Including Xrs2-FHA–Dependent Tel1 Activation"; PLOS Genetics; 2016
Organizations
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
ITI Life Sciences Seeks to Fund Innovative Drug Discovery Programme based on Ubiquitin

Natural UV radiation in winter not strong enough against SARS-CoV-2 - In winter the virus has a good chance of survival outside
Intermittent hormone therapy for prostate cancer inferior to continuous therapy
EMBO awards Installation Grants to seven talented European researchers
Category:Aminoglycoside_antibiotics
